# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-01-22 | **更新时间**: 09:10 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[22:00]` **Orca Bio 将在 2026 年 ASTCT 串联会议上展示其高精度细胞疗法的新临床数据**
  <br><small>🇬🇧 *Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT* [🔗Source](https://news.google.com/rss/articles/CBMiiwJBVV95cUxPUVkteERVRERZMVVkWEluTC02NXJWZ2pXTmxqb2pZaHY2VmN6S1VYc2MwS2RsdU11dDlfLWJFRFRpNHI0aGx5dGZFcDhEQmpZOU9VekJYTlhqVVFtNTFtRGpzSTF3OWNLMkdjMXQ3U0J3NVgxbGVqRFBuYVlEc2NmaEJ1V1ZsbEZmNnE4VTVOXzJGRkRuQl9YX3B5YXVydG5pV0NCbFF0bWswd01SeEVLQ3BQX0kycTk5RDRjTnIteW5ORnFIUDZNOV9CSWc5eHBsS0laNnF2elVJZ1BTeERMYnpYT19xdUlxaUJsaGtaOWUwbl9UNGEtZDJGUVo3UFJOZXpROXgtRDA3dFU?oc=5)</small>
- `[21:00]` **🏛️监管 | 美国 FDA 授予 Wugen 的 WU-CART-007 突破性疗法认定，用于治疗复发或难治性 T 细胞急性淋巴细胞白血病 / T 细胞淋巴细胞淋巴瘤**
  <br><small>🇬🇧 *U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic Lymphoma* [🔗Source](https://news.google.com/rss/articles/CBMi0wJBVV95cUxPeTRHTTRieGE0MXJTb2NZNFBwSFI5NzEzYVUtVDhsRjBlYXpCRU9zLUNub1Z0S3dRRUplMjFmSlZ3dWdjY2NVaWhOd3ltdTZKTWFTMWxUUWFvT1lZOVdJVmJZQWRFb0l4Y1pjZzN2S0d1elJKMFBfNnFnWDFTUmI2QWJ0Y3FGMzlucXBQWFRuZXU1aEtaTnp3S1d1V0Rjc2ZKMlB4ZlJHZjE4MUZZbUF3eHY4LTRkOTBlY25DV0dxY0dLdUJWMGZTdXV0YmIyVmJvTWNYdjRlN2lSRTdHU2RUdlk4ZHljX1F1S3BvZWRVQ1FSWlRSSUJXdXhRUlpBUjQxOXBfcDRWa0JqU2dfMy04cEdybFVERkRwbnYzc25OMzhYbnFWZXdDeFU3YVppbmJQcy1WWEQyWHFWeWx3Tl8tdjMzcVkzVDdLZkZFUUZpcXZfbnM?oc=5)</small>
- `[20:00]` **T1D 基金任命生物技术行业资深人士和细胞治疗专家 Teresa Foy 博士来加强专业知识，以推进下一代 1 型糖尿病（“T1D”）疗法**
  <br><small>🇬🇧 *The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes ("T1D") Therapies* [🔗Source](https://news.google.com/rss/articles/CBMi1AJBVV95cUxPaVdhSzZVZEE0NkhOM0tqR1VCUlQ0enVHb2J3c3BUWkNQb1NTQ1dLazFLRWE2VURuQmhmeTBwVUFnRlIyaGpkZ0FLQ2xWYVhaMTZYTWgxZDR5bW9LUVJlWVk3b0x5OUVRdm5tdnhKdjIwRmlTYkRpcjJUbXNuQW1vc3VnTnFFWThmSndzUVJkMW5aWmNpdlhGbmJadHQ5UWd0dzhhOVh1bVZFVXdrU3FuZ3VkUmNVeEt3QVZ3dEthekI5UzF5VkFvRmVhV2xOVTdzVXdudHhEcmFUcVVFdTd4ZjFaVDRzX1dMNXhUYTRqWTNFMXRSNWg2RFkyX1VxeWhSRUVBQWNkUTNVeEhMVWtuaFBDaFFsMWY2ajRySVJ5UzVTcGhCMVlHUWdGYjJnV0FwaDdHVGJBaW9sZ1M4OXVBWGdxdzFxc2ZRU19vVFJiSjZGelNV?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[08:04]` **🏛️监管 | 通用型CAR-T连获突破！茂行生物MT026临床数据登顶Nature子刊，MT027获批美国II期临床** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5YN2gxYnlmZ3NXM183NlV0VnZCV2x0YXh0X2I5ZnRia2dYZERwR2Jad3NFTUFZMkZhRWc1c2NBTl9HdzRVTHZqYVN1cEJlaF96NDQ2RVFHWUVLeHJVWFQ4Wjl0QmlVQWExWFRJUFQzeVJKc2NaQzlHTUFoVGRUdw?oc=5)
- `[17:41]` **🏛️监管 | 研发投入近4000万，上海医药肿瘤细胞疗法获批临床** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE50dWdpQ0lDYk9vWmxsMzY2UWNDZXJyczJzcEFscmQtaks4Y2dtR2hfOGh2MHNGcmJxODRGQ0hVdTBlV09uelZNZm4wWUEzbWZCa1ZLRUlJalhfYlBQQklnS3hJTm1IdzZnU1BiUG1YOWtCc09MZ2tKeTMzYVJTUQ?oc=5)
- `[17:36]` **🏛️监管 | 上药肿瘤细胞疗法获批临床** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE1nRm5VZkw3OWlKOXdwYjF4WWc0a2RUenFUaFREUzE2aUlEWl9UQzRrYlkzcVdfdHQ2MDd5dkRob24wYzFYblN0OU1fVGtScWdHSEoyQ0ZnT2ZsX0NhcmYtcjdhbG1reEpnSk5zWjhuUDAyNEFNX2I0bjZTemNUZw?oc=5)
